Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Non-Current Deffered Revenue (2018 - 2025)

Inventiva (IVA) posted quarterly Non-Current Deffered Revenue of $146669.5 for Q4 2025, up 28.28% year-over-year from $114339.7 in Q4 2024, and down 99.9% quarter-over-quarter from $142.6 million in Q2 2025.

Analysis

Inventiva (IVA) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends

Inventiva's Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $146669.5 for Q4 2025.

  • In Q4 2025, Non-Current Deffered Revenue rose 28.28% year-over-year to $146669.5; the TTM figure through Dec 2025 stood at $146669.5 (up 28.28% YoY), while the FY2025 annual figure was $146669.5, up 28.28% from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 stood at $146669.5, down from $142.6 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $142.6 million in Q2 2025, with the low at $56113.6 in Q4 2022.
  • The 4-year median for Non-Current Deffered Revenue is $81843.5 (2024), against an average of $20.5 million.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Deffered Revenue grew 23.21% in 2024, then soared 174167.96% in 2025.
  • Inventiva's Non-Current Deffered Revenue stood at $56113.6 in 2022, then soared by 34.22% to $75315.8 in 2023, then jumped by 51.81% to $114339.7 in 2024, then rose by 28.28% to $146669.5 in 2025.
  • Business Quant data shows IVA's Non-Current Deffered Revenue at $146669.5 in Q4 2025, $142.6 million in Q2 2025, and $114339.7 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 147.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Inventiva 893.85 Mn 893.85 Mn - 146,669.48
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 146,669.48
Jun 30, 2025 142,626.92
Dec 31, 2024 114,339.71
Dec 31, 2023 75,315.79
Jun 30, 2023 66,424.39
Dec 31, 2022 56,113.61
Dec 31, 2018 1.91 Mn